Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
US-10668067-B2 | Pyridine sulfonamides | 2016-07-20 |
US-2019167682-A1 | Pyridine sulfonamides | 2016-07-20 |
WO-2017213210-A1 | Heterocyclic compound | 2016-06-10 |
AU-2016341445-A1 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases | 2015-10-23 |
EP-3365335-A1 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases | 2015-10-23 |
US-10208024-B2 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases | 2015-10-23 |
US-2017260168-A1 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases | 2015-10-23 |
US-2019300511-A1 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases | 2015-10-23 |
WO-2017070708-A1 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases | 2015-10-23 |
AU-2016341445-B2 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases | 2015-10-23 |